000			02088 a2200553 4500
005			20250517163608.0
264		0	_c20180717
008			201807s 0 0 eng d
022			_a1937-6995
024	7		_a10.1007/s13181-017-0622-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aGoldberger, David
245	0	0	_aEvaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products. _h[electronic resource]
260			_bJournal of medical toxicology : official journal of the American College of Medical Toxicology _c12 2017
300			_a303-308 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAcetaminophen _xadverse effects
650	0	4	_aAcetylcysteine _xtherapeutic use
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAnalgesics, Non-Narcotic _xadverse effects
650	0	4	_aChemical and Drug Induced Liver Injury _xdrug therapy
650	0	4	_aDatabases, Factual
650	0	4	_aDrug Approval _xlegislation & jurisprudence
650	0	4	_aDrug Combinations
650	0	4	_aDrug Compounding
650	0	4	_aDrug Overdose _xdrug therapy
650	0	4	_aDrug and Narcotic Control _xlegislation & jurisprudence
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNaloxone _xtherapeutic use
650	0	4	_aNarcotic Antagonists _xadverse effects
650	0	4	_aPoison Control Centers
650	0	4	_aPolicy Making
650	0	4	_aPregnancy
650	0	4	_aPrescription Drugs _xadverse effects
650	0	4	_aProgram Evaluation
650	0	4	_aProtective Factors
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
650	0	4	_aUnited States
650	0	4	_aUnited States Food and Drug Administration _xlegislation & jurisprudence
650	0	4	_aYoung Adult
700	1		_aVearrier, David
773	0		_tJournal of medical toxicology : official journal of the American College of Medical Toxicology _gvol. 13 _gno. 4 _gp. 303-308
856	4	0	_uhttps://doi.org/10.1007/s13181-017-0622-8 _zAvailable from publisher's website
999			_c27370517 _d27370517